Who Paid My Doc
PoCC study in patients with PTSD
Research payments
$5,887,842
Through program year 2025, $5,887,842 in research payments was reported against PoCC study in patients with PTSD, across 241 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $65 | 1 |
| 2024 | Research | $736,017 | 42 |
| 2023 | Research | $3,746,595 | 75 |
| 2022 | Research | $1,357,054 | 90 |
| 2021 | Research | $48,111 | 33 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lawrence Ginsberg Houston, TX Named on 12 payments
- George Konis North Little Rock, AR Named on 7 payments
- Deborah York Salida, CO Named on 6 payments
- Benny Barnhart Wichita Falls, TX Named on 6 payments
- Alexander Bystritsky Los Angeles, CA Named on 6 payments
- Thomas Shiovitz Sherman Oaks, CA Named on 6 payments
- Adly Thebaud Orange City, FL Named on 5 payments
- Rishi Kakar Tamarac, FL Named on 5 payments
- Boadie Dunlop Atlanta, GA Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.